You will find in this section the recent latest new from the ICH.

3 June 2012

Press release from the MedDRA Management Board meeting in Fukuoka, 2-3 June 2012

The MSSO provided data on user uptake of the new MedDRA Version Analysis Tool (MVAT). MVAT assists users in understanding the differences between any two versions of MedDRA. Over 150 organisations have used MVAT since its launch...

14 May 2012

The Steering Committee endorses the establishment of an S1 EWG

In April 2012, the Steering Committee approved the S1 Concept Paper and Business Plan proposing to develop new guidance on rodent carcinogenicity testing. The aim of this new topic is to introduce a more comprehensive and...

10 May 2012

ICH Q11 reaches Step 4 of the ICH Process

The ICH Q11 Guideline on Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities) reached Step 4 of the ICH Process on 1 May 2012 and now enters the Implementation phase (Step...

3 May 2012

Additional E14 Q&As available on the ICH website

In April 2012, the ICH E14 Implementation Working Group (IWG) finalised under Step 4 of the ICH Process four additional Questions and Answers addressing Sex Differences, Incorporating New Technologies, Late Stage Monitoring...